Mass General Brigham’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$70.6M Hold
344,091
– – 15.48% 2
2026
Q2
$64.4M Hold
344,091
– – 17.85% 3
2026
Q1
$33.5M Hold
344,091
– – 7.14% 3
2025
Q4
$27.4M Buy
+344,091
New +$22.6M 3.38% 3
2024
Q3
$15.3M Hold
338,191
– – 35.15% 2
2024
Q2
$13.1M Hold
338,191
– – 63.9% 1
2024
Q1
$10.9M Buy
+338,191
New +$10M 19.08% 2
2023
Q2
– Sell
-338,191
Closed -$7.32M – 9
2023
Q1
$7.32M Buy
338,191
+316,767
+1,479% +$7.8M 5.71% 4
2022
Q4
$510K Buy
+21,424
New +$456K 0.36% 5

Other funds holding RVMD

Mass General Brigham's RVMD Position: Q3 2026 in Review

Mass General Brigham held its Revolution Medicines (RVMD) position steady in Q3 2026 at 344,091 shares worth $70.6M. The position accounts for 15.48% of the portfolio, ranked #2.

Mass General Brigham first reported a position in RVMD in Q4 2022 and has held it in 9 quarters since. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Mass General Brigham held 344,091 shares of Revolution Medicines worth $70.6M as of Q3 2026.
  • Mass General Brigham left its Revolution Medicines share count unchanged in Q3 2026.
  • Revolution Medicines made up 15.48% of Mass General Brigham's portfolio in Q3 2026, its #2 holding.
  • Mass General Brigham first reported a position in Revolution Medicines in Q4 2022 and has held it in 9 quarters since.
  • 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Mass General Brigham's 13F filing for Q3 2026, filed 3 Nov 2026.